Dr Mace A Nosovitch Md - 63017 Chesterfield, MO

Business Name: Dr Mace A Nosovitch Md
Categorized In: Doctors
Address: 232 South Woods Mill Road, Chesterfield, MO 63017
Phone Number: (314) 205-6917
Contact Person: Mace A Nosovitch
NAICS Code: 621111
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Founding Year: 2011
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Mauney Cheryl M MD - Chesterfield, MO 63017
Rames Richard D MD - Chesterfield, MO 63017
Mezei Leslie E MD - Chesterfield, MO 63017
St John's Cardiovascular Assoc - Chesterfield, MO 63017
Rotman Mitchell B MD - Chesterfield, MO 63017
Lux Paul S MD - Chesterfield, MO 63017
Miller Mark D MD - Chesterfield, MO 63017
Eisenstein Rhody MD - Chesterfield, MO 63017
Nemeth Patti M MD - Chesterfield, MO 63017
Thompson Jeffrey B MD - Chesterfield, MO 63017
Smith Kevin B MD - Chesterfield, MO 63017
Itoku Kendall A MD - Chesterfield, MO 63017
Callahan David J MD - Chesterfield, MO 63017
Pineda Marta MD - Chesterfield, MO 63017
Bosche Jr Alfred John MD - Chesterfield, MO 63017
Reiss Jacqueline MD - Chesterfield, MO 63017
Haikal Maged MD - Chesterfield, MO 63017
Thomson William M MD - Chesterfield, MO 63017
Zhang Bin MD - Chesterfield, MO 63017
Chesnut Michelle N MD - Chesterfield, MO 63017

Dr Mace A Nosovitch Md provides professional Doctors from its single location at the coordinates 38.649841,-90.507251.

The company offers B2C variables under the SIC code 8011 and NAICS code 621111, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2011, the company can now be visited at 232 South Woods Mill Road, Chesterfield, Missouri 63017 or contacted through representative Mace A Nosovitch at (314) 205-6917.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Dr Mace A Nosovitch Md through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.